Steven Cohen Olema Pharmaceuticals, Inc. Transaction History
Point72 Asset Management, L.P.
- $42.2 Billion
- Q4 2024
A detailed history of Steven Cohen (Point72 Asset Management, L.P.) transactions in Olema Pharmaceuticals, Inc. stock. As of the latest transaction made, Point72 Asset Management, L.P. holds 3,670,826 shares of OLMA stock, worth $18.5 Million. This represents 0.05% of its overall portfolio holdings.
Number of Shares
3,670,826
Previous 3,687,374
0.45%
Holding current value
$18.5 Million
Previous $44 Million
51.39%
% of portfolio
0.05%
Previous 0.12%
Shares
6 transactions
Others Institutions Holding OLMA
# of Institutions
161Shares Held
69.2MCall Options Held
235KPut Options Held
1.3K-
Bain Capital Life Sciences Investors, LLC Boston, MA7.47MShares$37.6 Million11.76% of portfolio
-
Paradigm Biocapital Advisors LP New York, NY7.3MShares$36.7 Million1.62% of portfolio
-
Bvf Inc San Francisco, CA5.72MShares$28.8 Million1.25% of portfolio
-
Black Rock Inc. New York, NY4MShares$20.1 Million0.0% of portfolio
-
Deep Track Capital, LP Greenwich, CT3.44MShares$17.3 Million0.88% of portfolio
About Olema Pharmaceuticals, Inc.
- Ticker OLMA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 40,419,600
- Market Cap $203M
- Description
- Olema Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of therapies for women's cancers. Its lead product candidate is OP-1250, an estrogen receptor (ER) antagonist and a selective ER degrader, which is in Phase 1/2 clinical trial for the treatment of recurrent, local...